New outbreaks cast doubt on China’s swine recovery


The US will have enough vaccines for 130 million by the end of March

(Bloomberg) – America’s vaccine supply for next month has just increased. Tuesday, Johnson & Johnson said it will be ready to ship 20 million doses of its one-dose vaccine next month. That adds to a growing increase in vaccine availability, according to a Bloomberg analysis of promises from drug makers. Along with vaccines from Pfizer Inc. and Moderna Inc., which require two doses, delivery targets up to next month will be enough to vaccinate 130 million Americans. Bloomberg’s analysis is based on statements from the companies, data on the number of vaccines already delivered and conversations with people familiar with the efforts who spoke on condition of anonymity. The analysis assumes that J & J’s vaccine, which has not yet been approved, will be licensed for use and that drug manufacturers will meet their new delivery targets, which is not a guarantee. The vaccine manufacturers appeared before the Congress on Tuesday to give an overview of the rollout so far. J&J will be ready to deliver 4 million doses upon approval and a total of 20 million doses in March, Richard Nettles, J & J’s vice president of US medical affairs for infectious diseases and vaccines, told Congress on Tuesday. That new promise updates an analysis published by Bloomberg last week that had assumed J&J would deliver fewer doses up front. “We are confident in our plans to deliver 100 million single-dose vaccines to the US during the first half of 2021, and We continue to partner with the US Government to explore all options to expedite delivery, “said Nettles. The company should be able to produce 1 billion doses globally by the end of the year, he said. Pfizer’s chief business officer John Young told lawmakers in his prepared remarks that the company had increased production and could supply 2 billion doses. doses worldwide by the end of the year. Young told Congress on Tuesday that the company plans to make 13 million doses available in the U.S. a week starting in mid-March. And Moderna said it plans to deliver about 55 million doses between now and the end of March, an average rate of about 11 million a week. In total, 240 million doses will have been made available by the end of the month, according to those. Projections: Currently in the U.S., about 1.4 million doses are administered per day, according to Bloomberg Vaccine Tracker, a number that would be higher if it weren’t for the winter storms that affected vaccination efforts across the country. Original Note: US Will Have Enough Vaccine for 130 Million by End of March For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source. © 2021 Bloomberg LP

Netherlands: curfew extended until March 15

“El Chapo’s” wife, detained without bail, faces possible life imprisonment